Abbott has reported data from the GUIDE-HF clinical trial, where its CardioMEMS HF System reduced mortality in New York Heart Association (NYHA) Class II, III and IV heart failure patients. A small implantable sensor, CardioMEMS is designed to wirelessly measure and track pulmonary artery pressure and heart rate.
If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.
Accordingly, you can do the same with others as well.